Press release
Pleural Diseases Therapeutics Market Expands with Immuno-Oncology Adoption: Why Advanced Thoracic Care Is Creating an USD 11.06 Billion Opportunity
Pleural Diseases Therapeutics Market
Get detailed market forecasts, competitive benchmarking, and pricing trends:
https://www.futuremarketinsights.com/reports/sample/rep-gb-16576
Quick Stats Snapshot
• Market Size (2025): USD 5.65 billion
• Estimated Value (2026): USD 6.00 billion
• Forecast (2036): USD 11.06 billion
• CAGR (2026-2036): 6.3%
• Incremental Opportunity: USD 5.06 billion
• Leading Treatment Segment: Chemotherapy (58.2% share)
• Leading Administration Route: Injectable (49.0% share)
• Fastest Growing Markets: USA and South Korea (6.4% CAGR)
Market Size and Forecast: Oncology Innovation Reshapes Pleural Disease Care
The pleural diseases therapeutics market is projected to grow from USD 6.00 billion in 2026 to USD 11.06 billion by 2036, reflecting a CAGR of 6.3%. Market expansion is being driven by increasing treatment demand for mesothelioma, malignant pleural effusion, pleurisy, and pneumothorax, alongside growing adoption of targeted biologics and minimally invasive thoracic procedures.
As healthcare systems prioritize multidisciplinary cancer management, pharmaceutical therapies, surgical procedures, and pleural drainage technologies are becoming central to hospital oncology and pulmonology infrastructure.
Key Growth Drivers: Immunotherapy, Procedural Demand, and Diagnostic Advances
1. Rising Mesothelioma Treatment Demand
Systemic chemotherapy regimens, including pemetrexed and cisplatin combinations, continue to dominate treatment protocols for malignant pleural mesothelioma. Expanding patient diagnosis rates are sustaining demand for oncology therapeutics.
2. Growth of Immuno-Oncology Therapies
Checkpoint inhibitor combinations such as nivolumab and ipilimumab are transforming first-line mesothelioma treatment. These biologic therapies are shifting market value toward high-cost targeted oncology solutions.
3. Expansion of Pleural Intervention Procedures
Thoracentesis, pleurodesis, indwelling pleural catheters, and video-assisted thoracoscopic surgery (VATS) are driving recurring demand for hospital consumables, drainage systems, and procedural devices.
Market Challenges: High Treatment Costs and Regulatory Complexity
Despite strong growth momentum, the market faces several operational and clinical barriers:
• High biologic therapy and immunotherapy costs
• Complex regulatory approval pathways for oncology drugs
• Reimbursement variability across healthcare systems
• Specialized infrastructure requirements for thoracic surgery and pleural interventions
These factors continue to shape procurement strategies and competitive positioning among global manufacturers.
Speak to Analyst: Customize insights for your business strategy:
https://www.futuremarketinsights.com/customization-available/rep-gb-16576
Segmentation Insights: Chemotherapy and Conventional Therapies Lead
By Treatment
• Chemotherapy dominates with 58.2% share in 2026
• Combination chemotherapy and systemic regimens remain first-line standards
• VATS, thoracostomy, pleurodesis, and catheter-based interventions support procedural demand
By Route of Administration
• Injectable therapies lead with 49.0% share due to intravenous chemotherapy and biologic delivery
• Intrapleural administration supports targeted pleural treatment approaches
By Technology
• Conventional therapies account for 52.0% share
• Targeted therapies and immuno-oncology segments represent the fastest-growing revenue opportunities
Regional Analysis: USA and South Korea Lead Global Growth
High-Growth Markets
• USA (6.4% CAGR): Supported by advanced oncology infrastructure and mesothelioma treatment capabilities
• South Korea (6.4% CAGR): Driven by oncology investment and clinical trial participation
• Japan (6.3% CAGR): Supported by aging demographics and thoracic surgery expertise
• EU (6.3% CAGR): Strengthened by harmonized oncology treatment frameworks
The market reflects growing global alignment toward precision oncology, advanced diagnostics, and minimally invasive pleural disease management.
Competitive Landscape: Oncology Pipelines Define Market Leadership
Competition is centered on oncology innovation, device integration, and specialist distribution capabilities.
Key players include:
• AstraZeneca plc
• Bristol-Myers Squibb
• Becton, Dickinson and Company
• Roche Holding AG (Genentech)
• Rocket Medical plc
• Novocure
• Medtronic
Leading companies are strengthening competitive positioning through biologic therapy development, thoracic device expansion, and strategic clinical collaborations.
Future Outlook: Precision Oncology Will Accelerate Market Evolution
Over the next decade, the pleural diseases therapeutics market will evolve beyond conventional chemotherapy toward integrated biologic, immunotherapy, and device-based treatment ecosystems. Advances in diagnostic imaging, biomarker testing, and minimally invasive thoracic surgery are expected to improve patient outcomes while expanding the treated population.
As healthcare systems invest in precision oncology and specialized thoracic care infrastructure, demand for advanced pleural disease therapeutics will continue to accelerate globally.
Executive Takeaways
• The market is projected to reach USD 11.06 billion by 2036
• Chemotherapy remains the leading treatment segment with 58.2% share
• Injectable therapies dominate due to biologic and intravenous oncology treatment demand
• USA and South Korea lead global growth at 6.4% CAGR
• Immuno-oncology and minimally invasive thoracic procedures are reshaping competitive dynamics
In an increasingly specialized oncology environment, pleural diseases therapeutics are becoming critical to multidisciplinary thoracic care-bridging pharmaceuticals, biologics, and procedural technologies to improve outcomes in complex pleural conditions.
Full Report for Detailed Insights:
https://www.futuremarketinsights.com/reports/pleural-diseases-therapeutics-market
Explore More Related Studies Published by FMI Research:
mRNA Vaccine Formulation Stability and Stress Test Systems Market https://www.futuremarketinsights.com/reports/mrna-vaccine-formulation-stability-and-stress-test-systems-market
Small Molecule API Market https://www.futuremarketinsights.com/reports/small-molecule-api-market
Biosimilar Monoclonal Antibody Comparability Test Platforms Market https://www.futuremarketinsights.com/reports/biosimilar-monoclonal-antibody-comparability-test-platforms-market
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
About Future Market Insights (FMI)
Future Market Insights, Inc. is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization trusted by Fortune 500 companies. With a global presence across the U.S., UK, India, and Dubai, FMI delivers data-driven insights across 30+ industries and 1200 markets worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pleural Diseases Therapeutics Market Expands with Immuno-Oncology Adoption: Why Advanced Thoracic Care Is Creating an USD 11.06 Billion Opportunity here
News-ID: 4517923 • Views: …
More Releases from Future Market Insights Inc
Citrus Seeds Market to Reach USD 9.5 Billion by 2036 as Disease Pressures and Or …
The global citrus seeds market is undergoing a major technological shift, moving from traditional open-pollinated sourcing toward highly specified, genetically advanced, and disease-resistant hybrid varieties. Driven by intensifying global disease pressures such as Huanglongbing (HLB or citrus greening) and the critical need for climate-resilient orchards, growers are aggressively modernizing their raw input strategies. According to comprehensive industry insights by Future Market Insights, the global market is projected to reach USD…
Citrus Yogurt Market to Top USD 4.0 Billion by 2036 as Functional Health and On- …
The global citrus yogurt market is undergoing a fundamental shift, moving from a standard fruit-flavored dairy segment into a sophisticated health and wellness platform. Driven by an accelerating shift toward natural ingredient profiles and a growing demand for functional snacks, consumers are increasingly seeking low-sugar, high-protein options with clean labels. According to comprehensive industry insights by Future Market Insights, the global market is projected to reach USD 2.7 billion in…
Clean Label Pectin Market to Surpass USD 274.7 Million by 2036 as Clean-Label Re …
The global clean label pectin market is experiencing a significant structural shift, transitioning from a traditional jam ingredient into a versatile, multi-application texturizing platform. Driven by an accelerating consumer rejection of synthetic gelling agents and gelatin, food manufacturers are increasingly prioritizing natural, plant-derived hydrocolloids to achieve clean-label positioning. According to comprehensive industry insights by Future Market Insights, the global market is projected to reach USD 149.1 million in 2026 and…
Citrus Water Market to Surpass USD 70.0 Million by 2036 as Functional Hydration …
The global citrus water market is undergoing a high-velocity transformation, evolving from a simple sub-category of flavored water into a highly sophisticated, functional hydration platform. Driven by a sweeping structural shift away from sugary carbonated soft drinks and rigid front-of-pack sugar regulations, health-conscious consumers are prioritizing clean-label, low-calorie alternatives. According to comprehensive industry insights by Future Market Insights, the global market is projected to reach USD 14.2 million in 2026…
More Releases for CAGR
[CAGR of 6.7%] Nanocoatings Market Size, Industry Share, CAGR, Regional Forecast …
The global Nanocoatings Market generated $10.7 billion in 2020, and is projected to reach $20.1 billion by 2030, growing at a CAGR of 6.7% from 2021 to 2030. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and wavering market trends.
Download sample PDF @ https://www.alliedmarketresearch.com/request-sample/2064
According to the report published by Allied Market Research,…
[CAGR of 5.3%] Pigments Market Size, Industry Share, CAGR, Regional Forecast, 20 …
A recent report by Allied Market Research provides a detailed analysis of the pigments market, highlighting its robust growth. The industry was valued at $27.2 billion in 2022 and is projected to surge to $45.4 billion by 2032, exhibiting an impressive CAGR of 5.3% from 2023 to 2032.
This research report identifies the growth drivers behind the market's expansion and delves into the market dynamics using advanced analytical frameworks…
Enzymes Market Expansion CAGR of 4.9% CAGR Anticipated 2025-2034
The Enzymes Market report is an in-depth examination of the global Enzymes Market's general consumption structure, development trends, sales techniques, and top nations' sales. The research looks at well-known providers in the global Enzymes Market industry, as well as market segmentation, competition, and the macroeconomic climate. A complete Enzymes Market analysis takes into account a number of aspects, including a country's population and business cycles, as well as market-specific microeconomic…
Waterproofing Membranes Market is Projected Grow at CAGR of 8% CAGR by 2033
The waterproofing membranes market is anticipated to witness a Compound Annual Growth Rate (CAGR) of 8.0% over the forecast period. By 2023, the estimated market value for waterproofing membranes is substantial, reaching US$ 31.5 billion.
These waterproofing materials comprise thin, impermeable membranes designed to collaborate with asphalt, providing a protective shield for the structural integrity of buildings. The asphalt component in these membranes acts as a safeguard, preserving the underlying membrane…
Electric Bed Market CAGR, Size, Share Grow USD 2,063 Million by 2030 CAGR 13.70%
Global electric bed market size is expected to be worth roughly USD 2,063 million by 2030, growing at a CAGR of more than 13.7% during the projected timeframe of 2022-2030, according to Ameco Research
A significant portion of the population over the age of 60, who often have reduced immunity levels and are more susceptible to neurological disorders, cardiac issues, tumors, and spinal cord compression, is anticipated to have a substantial…
Pediatric Radiology Market Size will Grow at CAGR 7.7% CAGR during 2017-2026
Pediatric Radiology Market:Overview
The pediatric radiology market is likely to register robust growth in the near future. Chronic illnesses among children including neurological disorders such as ADHD are on the rise. According to the US labor bureau, the demand for pediatrician is expected to grow by 24% on average by 2020. This is the highest average growth among all professionals in the United States.
Despite challenges such as training for new…
